INGR — Ingredion Incorporated
NYSE
Q4 2025 Earnings Call Summary
February 3, 2026
Ingredion Inc. Q4 2025 Earnings Call Summary
1. Key Financial Results and Metrics
- Q4 2025 Net Sales: $1.8 billion, down 2% year-over-year.
- Gross Profit: Decreased by 4%, with a gross margin of 24.5%.
- Operating Income: Reported at $220 million; adjusted operating income was $228 million.
- Full Year 2025 Net Sales: $7.2 billion, down 3% year-over-year.
- Full Year Gross Profit: Increased by 2%, with a gross margin of 25.3%.
- Full Year Operating Income: Reported at $1.016 billion; adjusted operating income was $1.028 billion.
- Adjusted EPS: Increased by 4.5% year-over-year.
2. Strategic Updates and Business Highlights
- Texture and Healthful Solutions: Continued growth with a 4% volume increase, driven by clean label ingredients. Operating income grew 16% year-over-year.
- Food and Industrial Ingredients LatAm: Despite challenges, achieved record operating income margins of over 21%. Focused on diversifying customer and product mix towards higher-margin ingredients.
- U.S./Canada Segment: Experienced a 7% decrease in net sales volume due to operational issues at the Argo facility, which impacted inventory production.
- Operational Improvements: Investments in modernization projects, including starch production efficiency enhancements and a blending center expansion, are expected to drive future growth.
- Cost Savings: Achieved $59 million in Cost2Compete run rate savings, exceeding the target of $50 million.
3. Forward Guidance and Outlook
- 2026 Net Sales Growth: Expected to be low single digits to mid-single digits, reflecting improved volume demand.
- Operating Income Growth: Anticipated to be low single digits for the full year.
- Adjusted EPS Guidance: Projected in the range of $11 to $11.80.
- Q1 2026 Outlook: Expected net sales to decline low single digits and operating income to decrease mid-double digits due to strong performance in Q1 2025.
4. Bad News, Challenges, or Points of Concern
- Operational Challenges: Ongoing issues at the Argo facility led to a significant impact on production and inventory, with an estimated $40 million impact on 2025 operating income.
- Volume Demand Softness: Noted declines in beverage sweetener volumes and challenges in the confectionery and paper sectors in LatAm.
- Manufacturing Cost Inflation: Anticipated inflation in manufacturing costs is expected to pressure margins, particularly in the U.S./Canada segment.
- Economic and Regulatory Risks: Potential impacts from currency fluctuations in Mexico and new taxes on sweetened beverages could affect demand.
5. Notable Q&A Insights
- Argo Facility Impact: Approximately two-thirds of the Q4 volume decline was attributed to Argo's operational issues, with expectations of gradual recovery throughout 2026.
- Texture & Healthful Solutions Pricing: Contract pricing for 2026 is expected to be slightly down, with challenges in fully covering manufacturing cost inflation.
- LatAm Volume Trends: Brewing adjunct volumes declined significantly, but food and beverage volumes showed positive growth in Mexico.
- GLP-1 Impact: The growth in GLP-1 medications is positively influencing the protein fortification business, which saw a 40% increase in sales.
Overall, Ingredion demonstrated resilience in a challenging environment, with strategic initiatives aimed at driving growth, although operational challenges and economic headwinds remain key concerns.
